- Administrative regional variation in cardiovascular risk among patients with gout: implications for the management of cardiovascular complications
-
Choi ST
- KMID: 2546236
- J Rheum Dis.
- 2023 Oct;30(4):209-210.
- doi: 10.4078/jrd.2023.0047
-
- CITED
-
- Close
- SHARE
-
- Close
- Epidemiology of systemic lupus erythematosus in Korea
-
Han JY, Cho SK, Sung YK
- KMID: 2546237
- J Rheum Dis.
- 2023 Oct;30(4):211-219.
- doi: 10.4078/jrd.2023.0037
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by diverse organ system disabilities, predominantly affecting young females. The clinical manifestations of SLE encompass various organs, including the kidney,... -
- CITED
-
- Close
- SHARE
-
- Close
- Elevated BMPR2 expression amplifies osteoblast differentiation in ankylosing spondylitis
-
Jo S, Lee SH, Jeon C, Jo HR, Ko E, Whangbo M, Kim TJ, Park YS, Kim TH
- KMID: 2546240
- J Rheum Dis.
- 2023 Oct;30(4):243-250.
- doi: 10.4078/jrd.2023.0024
Objective: Bone morphogenetic protein receptor type 2 (BMPR2) has been associated with radiographic changes in ankylosing spondylitis (AS), but further characterization of the cellular signaling pathway in osteoprogenitor (OP) is... -
- CITED
-
- Close
- SHARE
-
- Close
- Updates on ankylosing spondylitis: pathogenesis and therapeutic agents
-
Kim SH, Lee SH
- KMID: 2546238
- J Rheum Dis.
- 2023 Oct;30(4):220-233.
- doi: 10.4078/jrd.2023.0041
Ankylosing spondylitis (AS) is an autoinflammatory disease that manifests with the unique feature of enthesitis. Gut microbiota, HLA-B*27, and biomechanical stress mutually influence and interact resulting in setting off a... -
- CITED
-
- Close
- SHARE
-
- Close
- Recurrent focal myofasciitis of Behçet syndrome mimics infectious myofasciitis: a case report
-
Chung SW, Lee JH, Ha YJ, Kang EH, Lee YJ
- KMID: 2546243
- J Rheum Dis.
- 2023 Oct;30(4):268-271.
- doi: 10.4078/jrd.2023.0020
Behçet syndrome (BS) is a chronic inflammatory disease with multiorgan manifestations. However, muscular involvement in BS has rarely been reported. Herein, we report the case of a 30-year-old male with... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of COVID-19-associated multisystem inflammatory syndrome in children (MIS-C) and Kawasaki disease shock syndrome: case reports and literature review
-
Lee S, Kim D, Kim BJ, Rhim JW, Lee SY, Jeong DC
- KMID: 2546244
- J Rheum Dis.
- 2023 Oct;30(4):272-277.
- doi: 10.4078/jrd.2023.0022
Multisystem inflammatory syndrome in children (MIS-C) is a serious post-infectious complication of COVID-19 characterized by hyperinflammation and multi-organ dysfunction including shock. Shock is also seen in a severe form of... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatic steatosis index at diagnosis has the potential for forecasting end-stage kidney disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis
-
Choi HJ, Park PG, Park YB, Huh JH, Lee SW
- KMID: 2546242
- J Rheum Dis.
- 2023 Oct;30(4):260-267.
- doi: 10.4078/jrd.2023.0032
Objective: This study evaluated whether the hepatic steatosis index (HSI) at antineutrophil cytoplasmic antibody-associated vasculitis (AAV) diagnosis could forecast poor outcomes during the disease course in AAV patients. Methods: This study... -
- CITED
-
- Close
- SHARE
-
- Close
- Recovery and long-term renal outcome of patients with antineutrophil cytoplasmic antibody-associated vasculitis who are on dialysis at presentation
-
Lee YJ, Ahn SM, Oh JS, Kim YG, Lee CK, Yoo B, Hong S
- KMID: 2546241
- J Rheum Dis.
- 2023 Oct;30(4):251-259.
- doi: 10.4078/jrd.2023.0031
Objective: Renal involvement in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) can lead to severe renal dysfunction requiring dialysis at diagnosis. We aimed to study the clinical and pathologic characteristics of... -
- CITED
-
- Close
- SHARE
-
- Close
- Changes in the cholesterol profile of patients with rheumatoid arthritis treated with biologics or Janus kinase inhibitors
-
Koh JH, Lee BW, Kim WU
- KMID: 2546239
- J Rheum Dis.
- 2023 Oct;30(4):234-242.
- doi: 10.4078/jrd.2023.0030
Objective: To assess the effects of biological and targeted synthetic disease-modifying antirheumatic drugs (DMARDs) on lipid profiles in patients with moderate-to-severe rheumatoid arthritis (RA). Methods: This retrospective single-center observational study included... -
- CITED
-
- Close
- SHARE
-
- Close
